Outsourced Clinical Trials & Formulation Market Segmented By Oral dosage Forms, Injectable Dosage Forms Product in API Manufacturing, Fill-Finish Product Manufacturing, Drug Product Development, Packaging / labeling
Industry: Healthcare
Published Date: March-2022
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 213
Report ID: PMRREP33016
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation/ Development Trends
4. Key Success factors
4.1. Key Strategies Adopted by market players
4.2. Porters Analysis
4.3. PESTLE Analysis
4.4. Key Regulations
4.5. Value Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Rising Geriatric Population
5.2.2. Rising incidence of Chronic Diseases
5.2.3. Patent Expiry and Increasing Demand For Generic Drugs
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID19 Crisis Analysis
6.1. Current Perspectives on Coronavirus Outbreak
6.2. Current Economic Outlook & Recovery Scenario
6.3. COVID19 and Impact Analysis
6.3.1. Revenue By Product
6.3.2. Revenue By End User
6.3.3. Revenue By Region
7. Global Outsourced Clinical Trials & Formulation Market Demand (in Value or Size in US$ Mn) Analysis 2016-2021 and Forecast 2022-2027, by Product
7.1. Historical Market Value (US$ Mn) Analysis, 2016-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2027
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Outsourced Clinical Trials & Formulation Market Analysis 2016-2021 and Forecast 2022-2027, by Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Product, 2016-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022-2027
8.3.1. Oral Dosage Products
8.3.1.1. Solid dosage Product
8.3.1.2. Liquid Dosage Product
8.3.1.3. Semi-solid Dosage Product
8.3.2. Injectable Dosage Product
8.3.3. Others
8.4. Market Attractiveness Analysis By Product
9. Global Outsourced Clinical Trials & Formulation Market Analysis 2016-2021 and Forecast 2022-2027, by Application
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Application, 2016-2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022-2027
9.3.1. API Manufacturing
9.3.2. Fill Finish Product Manufacturing
9.3.3. Drug Product Development
9.3.4. Packaging / Labelling
9.3.5. Others
9.4. Market Attractiveness Analysis By Application
10. Global Outsourced Clinical Trials & Formulation Market Analysis 2016-2021 and Forecast 2022-2027, by End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By End User, 2016-2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022 - 2027
10.3.1. Big Pharmaceutical and Biotech Companies
10.3.2. Small and Medium Size Pharma/Biotech Companies
10.3.3. Emerging/Virtual Pharma Companies
10.3.4. Nutraceutical Companies
10.4. Market Attractiveness Analysis By End User
11. Global Outsourced Clinical Trials & Formulation Market Analysis 2016-2021 and Forecast 2022-2027, by Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2016-2021
11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022 - 2027
11.3.1. North America
11.3.2. Europe
11.3.3. Asia pacific
11.3.4. Rest of the World
11.4. Market Attractiveness Analysis By Region
12. North America Outsourced Clinical Trials & Formulation Market Analysis 2016-2021 and Forecast 2022-2027
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Product
12.3.3. By Application
12.3.4. By End User
12.4. Market Attractiveness Analysis
12.5. Drivers and Restraints - Impact Analysis
13. Europe Outsourced Clinical Trials & Formulation Market Analysis 2016-2021 and Forecast 2022-2027
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027
13.3.1. By Country
13.3.1.1. U.K.
13.3.1.2. Germany
13.3.1.3. France
13.3.1.4. Italy
13.3.1.5. Spain
13.3.1.6. BENELUX
13.3.1.7. Russia
13.3.1.8. BENELUX
13.3.1.9. Rest of Europe
13.3.2. By Product
13.3.3. By Application
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.5. Drivers and Restraints - Impact Analysis
14. Asia Pacific Outsourced Clinical Trials & Formulation Market Analysis 2016-2021 and Forecast 2022-2027
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027
14.3.1. By Country
14.3.1.1. China
14.3.1.2. Japan
14.3.1.3. South Korea
14.3.1.4. India
14.3.1.5. Australia and New Zealand
14.3.1.6. ASEAN
14.3.1.7. Rest of Asia Pacific
14.3.2. By Product
14.3.3. By Application
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.5. Drivers and Restraints - Impact Analysis
15. Rest of the World Outsourced Clinical Trials & Formulation Market Analysis 2016-2021 and Forecast 2022-2027
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027
15.3.1. By Product
15.3.2. By Application
15.3.3. By End User
15.4. Market Attractiveness Analysis
15.5. Drivers and Restraints - Impact Analysis
16. Market Structure Analysis
16.1. Market Analysis y Tier of Companies
16.2. Market Share Analysis of Top Players
17. Competition Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Competition Deep Dive (Tentative List)
17.3.1. Lonza Group
17.3.1.1. Overview
17.3.1.2. Product Portfolio
17.3.1.3. Key Financials
17.3.1.4. SWOT Analysis
17.3.1.5. Sales Footprint
17.3.1.6. Strategy Overview
17.3.2. Catalent, Inc.
17.3.2.1. Overview
17.3.2.2. Product Portfolio
17.3.2.3. Key Financials
17.3.2.4. SWOT Analysis
17.3.2.5. Sales Footprint
17.3.2.6. Strategy Overview
17.3.3. Thermo Fisher Scientific Inc. (Patheon)
17.3.3.1. Overview
17.3.3.2. Product Portfolio
17.3.3.3. Key Financials
17.3.3.4. SWOT Analysis
17.3.3.5. Sales Footprint
17.3.3.6. Strategy Overview
17.3.4. Piramal Pharma Solutions
17.3.4.1. Overview
17.3.4.2. Product Portfolio
17.3.4.3. Key Financials
17.3.4.4. SWOT Analysis
17.3.4.5. Sales Footprint
17.3.4.6. Strategy Overview
17.3.5. BioXcellence (Boehringer Ingelheim International GmbH)
17.3.5.1. Overview
17.3.5.2. Product Portfolio
17.3.5.3. Key Financials
17.3.5.4. SWOT Analysis
17.3.5.5. Sales Footprint
17.3.5.6. Strategy Overview
17.3.6. Siegfried Holding AG
17.3.6.1. Overview
17.3.6.2. Product Portfolio
17.3.6.3. Key Financials
17.3.6.4. SWOT Analysis
17.3.6.5. Sales Footprint
17.3.6.6. Strategy Overview
17.3.7. Evotec A.G.
17.3.7.1. Overview
17.3.7.2. Product Portfolio
17.3.7.3. Key Financials
17.3.7.4. SWOT Analysis
17.3.7.5. Sales Footprint
17.3.7.6. Strategy Overview
17.3.8. Ascendia Pharmaceuticals
17.3.8.1. Overview
17.3.8.2. Product Portfolio
17.3.8.3. Key Financials
17.3.8.4. SWOT Analysis
17.3.8.5. Sales Footprint
17.3.8.6. Strategy Overview
17.3.9. Experic Services
17.3.9.1. Overview
17.3.9.2. Product Portfolio
17.3.9.3. Key Financials
17.3.9.4. SWOT Analysis
17.3.9.5. Sales Footprint
17.3.9.6. Strategy Overview
17.3.10. Quotient Sciences
17.3.10.1. Overview
17.3.10.2. Product Portfolio
17.3.10.3. Key Financials
17.3.10.4. SWOT Analysis
17.3.10.5. Sales Footprint
17.3.10.6. Strategy Overview
17.3.11. Velesco Pharmaceutical Services, Inc.
17.3.11.1. Overview
17.3.11.2. Product Portfolio
17.3.11.3. Key Financials
17.3.11.4. SWOT Analysis
17.3.11.5. Sales Footprint
17.3.11.6. Strategy Overview
17.3.12. Elements Group (Avomeen)
17.3.12.1. Overview
17.3.12.2. Product Portfolio
17.3.12.3. Key Financials
17.3.12.4. SWOT Analysis
17.3.12.5. Sales Footprint
17.3.12.6. Strategy Overview
17.3.13. VxP Pharma
17.3.13.1. Overview
17.3.13.2. Product Portfolio
17.3.13.3. Key Financials
17.3.13.4. SWOT Analysis
17.3.13.5. Sales Footprint
17.3.13.6. Strategy Overview
17.3.14. Adare Pharmaceuticals, Inc.
17.3.14.1. Overview
17.3.14.2. Product Portfolio
17.3.14.3. Key Financials
17.3.14.4. SWOT Analysis
17.3.14.5. Sales Footprint
17.3.14.6. Strategy Overview
17.3.15. KP Pharmaceutical Technology Inc.
17.3.15.1. Overview
17.3.15.2. Product Portfolio
17.3.15.3. Key Financials
17.3.15.4. SWOT Analysis
17.3.15.5. Sales Footprint
17.3.15.6. Strategy Overview
17.3.16. Enteris Biopharma, Inc.
17.3.16.1. Overview
17.3.16.2. Product Portfolio
17.3.16.3. Key Financials
17.3.16.4. SWOT Analysis
17.3.16.5. Sales Footprint
17.3.16.6. Strategy Overview
17.3.17. Aenova Holding GmbH
17.3.17.1. Overview
17.3.17.2. Product Portfolio
17.3.17.3. Key Financials
17.3.17.4. SWOT Analysis
17.3.17.5. Sales Footprint
17.3.17.6. Strategy Overview
17.3.18. Ardena Holding NV
17.3.18.1. Overview
17.3.18.2. Product Portfolio
17.3.18.3. Key Financials
17.3.18.4. SWOT Analysis
17.3.18.5. Sales Footprint
17.3.18.6. Strategy Overview
17.3.19. Pharmaceutics International, Inc.
17.3.19.1. Overview
17.3.19.2. Product Portfolio
17.3.19.3. Key Financials
17.3.19.4. SWOT Analysis
17.3.19.5. Sales Footprint
17.3.19.6. Strategy Overview
17.3.20. Alcami Corporation, Inc.
17.3.20.1. Overview
17.3.20.2. Product Portfolio
17.3.20.3. Key Financials
17.3.20.4. SWOT Analysis
17.3.20.5. Sales Footprint
17.3.20.6. Strategy Overview
17.3.21. NextPharma Technologies
17.3.21.1. Overview
17.3.21.2. Product Portfolio
17.3.21.3. Key Financials
17.3.21.4. SWOT Analysis
17.3.21.5. Sales Footprint
17.3.21.6. Strategy Overview
17.3.22. Corden Pharma International GmbH
17.3.22.1. Overview
17.3.22.2. Product Portfolio
17.3.22.3. Key Financials
17.3.22.4. SWOT Analysis
17.3.22.5. Sales Footprint
17.3.22.6. Strategy Overview
17.3.23. Corerx, Inc.
17.3.23.1. Overview
17.3.23.2. Product Portfolio
17.3.23.3. Key Financials
17.3.23.4. SWOT Analysis
17.3.23.5. Sales Footprint
17.3.23.6. Strategy Overview
17.3.24. Recipharm AB
17.3.24.1. Overview
17.3.24.2. Product Portfolio
17.3.24.3. Key Financials
17.3.24.4. SWOT Analysis
17.3.24.5. Sales Footprint
17.3.24.6. Strategy Overview
17.3.25. Pace Analytical Services, LLC
17.3.25.1. Overview
17.3.25.2. Product Portfolio
17.3.25.3. Key Financials
17.3.25.4. SWOT Analysis
17.3.25.5. Sales Footprint
17.3.25.6. Strategy Overview
17.3.26. Almac Group, Inc.
17.3.26.1. Overview
17.3.26.2. Product Portfolio
17.3.26.3. Key Financials
17.3.26.4. SWOT Analysis
17.3.26.5. Sales Footprint
17.3.26.6. Strategy Overview
17.3.27. Cambrex Corporation
17.3.27.1. Overview
17.3.27.2. Product Portfolio
17.3.27.3. Key Financials
17.3.27.4. SWOT Analysis
17.3.27.5. Sales Footprint
17.3.27.6. Strategy Overview
17.3.28. Rottendorf Pharma GmbH
17.3.28.1. Overview
17.3.28.2. Product Portfolio
17.3.28.3. Key Financials
17.3.28.4. SWOT Analysis
17.3.28.5. Sales Footprint
17.3.28.6. Strategy Overview
17.3.29. Glatt GmbH
17.3.29.1. Overview
17.3.29.2. Product Portfolio
17.3.29.3. Key Financials
17.3.29.4. SWOT Analysis
17.3.29.5. Sales Footprint
17.3.29.6. Strategy Overview
17.3.30. Hovione
17.3.30.1. Overview
17.3.30.2. Product Portfolio
17.3.30.3. Key Financials
17.3.30.4. SWOT Analysis
17.3.30.5. Sales Footprint
17.3.30.6. Strategy Overview
17.3.31. Aphena Pharma Solutions
17.3.31.1. Overview
17.3.31.2. Product Portfolio
17.3.31.3. Key Financials
17.3.31.4. SWOT Analysis
17.3.31.5. Sales Footprint
17.3.31.6. Strategy Overview
17.3.32. HERMES PHARMA GmbH
17.3.32.1. Overview
17.3.32.2. Product Portfolio
17.3.32.3. Key Financials
17.3.32.4. SWOT Analysis
17.3.32.5. Sales Footprint
17.3.32.6. Strategy Overview
18. Assumptions and Acronyms Used
19. Research Methodology
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Table 01: Global Outsourced Clinical Trials & Formulation Market Size Analysis (US$ Mn) Analysis 2016-2021 and Forecast 2022 - 2027, By Product
Table 02: Global Outsourced Clinical Trials & Formulation Market Size Analysis (US$ Mn) Analysis 2016-2021 and Forecast 2022 - 2027, By Application
Table 03: Global Outsourced Clinical Trials & Formulation Market Size Analysis (US$ Mn) Analysis 2016-2021 and Forecast 2022 - 2027, By End User
Table 04: Global Outsourced Clinical Trials & Formulation Market Size Analysis (US$ Mn) Analysis 2016-2021 and Forecast 2022 - 2027, By Region
Table 05: North America Outsourced Clinical Trials & Formulation Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2027, By Product
Table 06: North America Outsourced Clinical Trials & Formulation Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2027, By Application
Table 07: North America Outsourced Clinical Trials & Formulation Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2027, By End User
Table 08: Europe Outsourced Clinical Trials & Formulation Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2027, By Product
Table 09: Europe Outsourced Clinical Trials & Formulation Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2027, By Application
Table 10: Europe Outsourced Clinical Trials & Formulation Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2027, By End User
Table 11: Asia Pacific Outsourced Clinical Trials & Formulation Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2027, By Product
Table 12: Asia Pacific Outsourced Clinical Trials & Formulation Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2027, By Application
Table 13: Asia Pacific Outsourced Clinical Trials & Formulation Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2027, By End User
Table 14: Rest of the World Outsourced Clinical Trials & Formulation Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2027, By Product
Table 15: Rest of the World Outsourced Clinical Trials & Formulation Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2027, By Application
Table 16: Rest of the World Outsourced Clinical Trials & Formulation Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2027, By End User
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
Figure 01: Global Outsourced Clinical Trials & Formulation Historical Market Size and Y-o-Y, 2016-2021
Figure 02: Global Outsourced Clinical Trials & Formulation Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2027
Figure 03: Global Outsourced Clinical Trials & Formulation Market Absolute $ Opportunity, 2022-2027
Figure 04: Global Outsourced Clinical Trials & Formulation Market Share Analysis (%) By Product, 2022 & 2027
Figure 05: Global Outsourced Clinical Trials & Formulation Market Y-o-Y Growth (%) By Product, 2022-2027
Figure 06: Global Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By Product
Figure 07: Global Outsourced Clinical Trials & Formulation Market Analysis by Application -2022 & 2027
Figure 08: Global Outsourced Clinical Trials & Formulation Market Y-o-Y Growth Projections by Application, 2022-2027
Figure 09: Global Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By Application
Figure 10: Global Outsourced Clinical Trials & Formulation Market Share Analysis (%) By End User, 2022 & 2027
Figure 11: Global Outsourced Clinical Trials & Formulation Market Y-o-Y Growth (%) By End User, 2022-2027
Figure 12: Global Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By End User
Figure 13: Global Outsourced Clinical Trials & Formulation Market Share Analysis (%) By Region, 2022 & 2027
Figure 14: Global Outsourced Clinical Trials & Formulation Market Y-o-Y Growth (%) By Region, 2022-2027
Figure 15: Global Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By Region
Figure 16: North America Outsourced Clinical Trials & Formulation Market Analysis Market Share, By Product (2021)
Figure 17: North America Outsourced Clinical Trials & Formulation Market Analysis Market Share, By Application (2021
Figure 18: North America Outsourced Clinical Trials & Formulation Market Analysis Market Share, By End User (2021)
Figure 19: North America Outsourced Clinical Trials & Formulation Market Analysis Market Share, By Country (2021)
Figure 20: North America Outsourced Clinical Trials & Formulation Historical Market Value (US$ Mn) Analysis, 2016-2021
Figure 21: North America Outsourced Clinical Trials & Formulation Current and Future Market Value (US$ Mn), 2022-2027 & Y-o-Y Growth Trend Analysis
Figure 22: North America Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By Country
Figure 23: North America Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By Product
Figure 24: North America Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By End User
Figure 25: North America Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By Application
Figure 26: Europe Outsourced Clinical Trials & Formulation Market Analysis Market Share, By Product (2021)
Figure 27: Europe Outsourced Clinical Trials & Formulation Market Analysis Market Share, By Application (2021)
Figure 28: Europe Outsourced Clinical Trials & Formulation Market Analysis Market Share, By Country (2021)
Figure 29: Europe Outsourced Clinical Trials & Formulation Market Analysis Market Share, By End User (2021)
Figure 30: Europe Outsourced Clinical Trials & Formulation Historical Market Value (US$ Mn) Analysis, 2016-2021
Figure 31: Europe Outsourced Clinical Trials & Formulation Current and Future Market Value (US$ Mn), 2022-2027 & Y-o-Y Growth Trend Analysis
Figure 32: Europe Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By Country
Figure 33: Europe Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By Product
Figure 34: Europe Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By Application
Figure 35: Europe Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By End User
Figure 36: Asia Pacific Outsourced Clinical Trials & Formulation Market Analysis Market Share, By Product (2021)
Figure 37: Asia Pacific Outsourced Clinical Trials & Formulation Market Analysis Market Share, By Application (2021)
Figure 38: Asia Pacific Outsourced Clinical Trials & Formulation Market Analysis Market Share, By Country (2021)
Figure 39: Asia Pacific Outsourced Clinical Trials & Formulation Market Analysis Market Share, By End User (2021)
Figure 40: Asia Pacific Outsourced Clinical Trials & Formulation Historical Market Value (US$ Mn) Analysis, 2016-2021
Figure 41: Asia Pacific Outsourced Clinical Trials & Formulation Current and Future Market Value (US$ Mn), 2022-2027 & Y-o-Y Growth Trend Analysis
Figure 42: Asia Pacific Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By Country
Figure 43: Asia Pacific Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By Product
Figure 44: Asia Pacific Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By Application
Figure 45: Asia Pacific Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By End User
Figure 46: Rest of the World Outsourced Clinical Trials & Formulation Market Analysis Market Share, By Product (2021)
Figure 47: Rest of the World Outsourced Clinical Trials & Formulation Market Analysis Market Share, By Application (2021)
Figure 48: Rest of the World Outsourced Clinical Trials & Formulation Market Analysis Market Share, By End User (2021)
Figure 49: Rest of the World Outsourced Clinical Trials & Formulation Historical Market Value (US$ Mn) Analysis, 2016-2021
Figure 50: Rest of the World Outsourced Clinical Trials & Formulation Current and Future Market Value (US$ Mn), 2022-2027 & Y-o-Y Growth Trend Analysis
Figure 51: Rest of the World Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By Application
Figure 52: Rest of the World Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By End User
